GC001 How Would You Anaesthetise Me - Pharmacology Of Anaesthetic Drugs
The pharmacology of anaesthetic drugs encompasses the mechanisms of action, pharmacokinetics, and pharmacodynamics of intravenous induction agents, inhalational anaesthetics, neuromuscular blocking agents, opioids, and local anaesthetics used to achieve the triad of unconsciousness, analgesia, and muscle relaxation during general anaesthesia.
How Would You Anaesthetise Me? — Pharmacology of Anaesthetic Drugs
Big Idea: This lecture walks through the entire perioperative anaesthetic journey from the patient's perspective — what happens before, during, and after general anaesthesia — while systematically introducing the pharmacology of every drug class used. It also covers regional anaesthesia, its types, and its complications. Think of it as "a guided tour through the operating theatre, with drug names attached to every step."
Learning Objectives (from the lecture): [1]
- Describe the purpose of general anaesthesia and the means to achieve it
- Name and classify commonly used anaesthetic and analgesic drugs
- Name some types of regional anaesthesia
General anaesthesia (GA): Reduced level of consciousness and response to stimuli [1]
Regional anaesthesia (RA): Loss of sensation to a body part or region — patient can be fully awake, sedated, or unconscious [1]
The slide groups monitored anaesthesia care (MAC) with “conscious sedation”: the patient remains spontaneously ventilating while the anaesthesiologist is present and titrates drugs. [1]
Current terminology: MAC is an anaesthesia service, not a fixed depth of sedation. Minimal, moderate and deep sedation form a continuum, and a patient may unintentionally become more deeply sedated. The person providing sedation must monitor continuously and be able to rescue the patient from the next deeper level. [7]
| Type | Consciousness | Ventilation | Key Feature |
|---|---|---|---|
| GA | Unconscious | Spontaneous or controlled, depending on technique | Reversible unconsciousness with loss of response to stimulation |
| RA | Usually awake; sedation or GA may be added | Usually spontaneous | Nerve blockade of a region |
| MAC | Sedation depth varies | Usually spontaneous, but airway/ventilation may become impaired as depth increases | An anaesthesia service with continuous assessment and readiness to rescue |
| Combined GA + RA | Unconscious | Controlled | Best of both worlds (e.g., GA + epidural) |
Why combinations? Some surgeries require both muscle relaxation (GA) and excellent regional analgesia (epidural for thoracotomy). Regional techniques also reduce the total dose of systemic drugs needed, improving haemodynamic stability and postoperative pain control.
"Anaesthesia" = without sensation. Reversible (hopefully!). Providing general anaesthesia involves more than just dampening sensation. [1]
From the patient's perspective: "I don't want to feel or remember anything." From the surgeon's perspective: "I want the patient's muscles to be relaxed and don't want any movements."
The Five Objectives of GA
Hypnosis, Amnesia, Analgesia, Areflexia, +/- Muscle Relaxation [1]
| Objective | What it means | Why it's needed | Drug class achieving it |
|---|---|---|---|
| Hypnosis | Loss of consciousness | Patient unaware during surgery | Induction agents, volatile agents, propofol |
| Amnesia | No memory formation | Prevent psychological trauma of awareness | Same as hypnosis agents; midazolam adds amnesia |
| Analgesia | Pain abolition | Body still "feels" surgical trauma even when unconscious → stress response | Opioids, regional techniques, paracetamol, NSAIDs |
| Areflexia | Suppression of autonomic reflexes | Prevent dangerous reflex responses (laryngospasm, bradycardia, hypertension) | Opioids, deeper anaesthesia |
| Muscle relaxation | Paralysis of skeletal muscle | Facilitate intubation, surgical access (abdominal surgery), prevent movement | Neuromuscular blocking agents (NMBAs) |
Safety distinction — paralysis is not anaesthesia
An NMBA produces immobility only. It provides no hypnosis, amnesia or analgesia, and can conceal purposeful movement in an inadequately anaesthetised patient. Adequate anaesthesia and analgesia must therefore continue whenever paralysis is present.
Why Analgesia Matters Even Under GA
Just because the patient is unconscious does NOT mean the body stops responding to surgical pain. Nociceptive signals still travel → sympathetic activation → tachycardia, hypertension, increased oxygen consumption. This "stress response" worsens outcomes. That's why we give opioids and analgesics intraoperatively — not just for the patient's comfort, but to blunt harmful physiological responses.
This is the concept of balanced anaesthesia: using a combination of drugs at lower doses, each targeting a different objective, to minimize side effects while optimizing all five goals. [3]
3. Perioperative Sequence — Step by Step
History (general, anaesthetic history — especially risk for aspiration), Examination (CVS, Respiratory, Airway, other relevant parts), Investigations [1]
Anaesthetic history is critical: previous difficult intubation, adverse reactions to anaesthetic drugs, family history of malignant hyperthermia, history of PONV (post-operative nausea and vomiting).
Airway assessment combines mouth opening, dentition, tongue/oropharyngeal view, mandibular space, neck movement and previous airway records; no single bedside test reliably predicts difficulty. Examination is tailored to the planned technique—for example, inspect the lumbar spine when neuraxial anaesthesia is contemplated, as shown on the slide.
3.2 Preparation of the Patient
Instructions regarding comorbidities, medications, fasting instructions, other preparations (e.g., bringing CPAP machine to hospital) [1]
Minimize the chance of aspiration during induction of and emergence from anaesthesia [1]
| Substance | Fasting Time |
|---|---|
| Clear fluids (water, clear juice without pulp, carbonated beverages, carbohydrate-rich nutritional drinks, clear tea, black coffee) | 2 hours |
| Breast milk | 4 hours |
| Infant formula | 6 hours |
| Solids and non-human milk | 6 hours |
High Yield — Fasting Rules
The slide’s exam mnemonic is “2 clear, 4 breast, 6 formula/light solid.” A fatty or fried meal, meat or otherwise heavy meal commonly requires 8 or more hours. These are minimum intervals for otherwise healthy elective patients; delayed gastric emptying, obstruction, emergency surgery, pregnancy, diabetes and medicines that affect gastric emptying require an individual plan. Follow the local anaesthetic team’s instructions rather than applying the table mechanically. [8]
Common Mistake
Students often think fasting is only needed for GA. For an operative regional technique, the lecture’s safety message is to prepare for possible conversion to GA, including the prescribed fasting plan. [1] This does not mean imposing elective fasting indiscriminately on every bedside local-anaesthetic or analgesic block; procedure, sedation plan, aspiration risk and local policy matter.
The slide asks students to obtain the medication history and give explicit instructions; it does not supply a universal stop list. Anticoagulant/antiplatelet interruption depends on the drug, renal function, bleeding risk, thrombotic risk and whether neuraxial anaesthesia is planned. Diabetes medicines, insulin, GLP-1 receptor agonists and SGLT2 inhibitors also need procedure- and patient-specific instructions. Never tell a patient to stop these drugs from a memorised table—use current local guidance and the anaesthesiologist’s plan.
Before induction: pulse oximetry, blood pressure and ECG. Once the airway is instrumented: waveform end-tidal CO₂ monitoring. [1]
Why end-tidal CO₂ (ETCO₂)? Sustained waveform capnography helps confirm tracheal placement and continuously shows ventilation. The image-heavy monitor slides also identify the ECG/heart rate, plethysmographic waveform and SpO₂, non-invasive blood pressure, inspired and expired volatile-agent concentration, and capnogram/ETCO₂. Current monitoring standards additionally require temperature and, according to technique, inspired/expired oxygen and anaesthetic gases, ventilation variables, quantitative neuromuscular monitoring and processed EEG for TIVA with neuromuscular blockade. [9]
Induction → Maintenance → Emergence and Recovery [1]
4. Pharmacology of Induction Agents
Induction: the process of causing general anaesthesia by the administration of pharmaceutics [1]
Most commonly via the intravenous route. Inhalational route can be used. [1]
Propofol, Thiopentone, Etomidate, Ketamine [1]
| Agent | Mechanism | Onset / Duration | Advantages | Disadvantages | Special Notes |
|---|---|---|---|---|---|
| Propofol | Positive modulation of GABA-A receptor → global CNS depression | Rapid onset (15–30s); short duration after a bolus | Smooth induction, antiemetic properties, can be used for both induction AND maintenance (TIVA) | Pain on injection, hypotension, bradycardia, respiratory depression | White lipid emulsion shown being injected on the slide |
| Thiopentone (thiopental) | Barbiturate — enhances GABA-A | Very rapid onset; ultra-short acting (redistribution) | Rapid, reliable | Cardiovascular depression, tissue necrosis if extravasated, NO analgesic properties, porphyria contraindication | Historically important; less used now |
| Etomidate | GABA-A modulation | Rapid onset | Haemodynamically stable — minimal cardiovascular effects | Adrenocortical suppression (inhibits 11β-hydroxylase), myoclonus, pain on injection | Used when haemodynamic stability is critical (e.g., cardiac patients, hypovolaemia) |
| Ketamine | Non-competitive NMDA receptor antagonist | Onset ~1 min; duration 10–15 min | Often preserves blood pressure and spontaneous ventilation better than propofol; bronchodilation, analgesia, IM option | Emergence phenomena, secretions; cardiovascular stimulation may be undesirable | Its haemodynamic effect is not guaranteed in catecholamine-depleted shock |
High Yield — When to Use Which Induction Agent
- Propofol: Default for most patients. Smooth, antiemetic, versatile.
- Etomidate: When you CANNOT afford a BP drop (e.g., shocked patient, severe cardiac disease).
- Ketamine: When you need haemodynamic stability AND analgesia (trauma, paediatrics, asthma — bronchodilation).
- Thiopentone: Niche use; historically for rapid sequence induction. Contraindicated in porphyria.
Sevoflurane, Nitrous Oxide [1]
- Sevoflurane ("the yellow stuff" [3]): Non-irritant to airways → suitable for inhalational induction, especially in children (paediatric patients who can't tolerate IV cannulation before induction)
- Nitrous oxide (N₂O, "laughing gas", Entonox when mixed 50:50 with O₂): Weak anaesthetic and analgesic adjunct. Its MAC exceeds 100%, so it is not a sole modern general-anaesthetic agent at normal pressure.
Why gas induction? In children or needle-phobic patients, you can hold a mask with sevoflurane over the face → child breathes in → loses consciousness → THEN establish IV access.
5. Neuromuscular Blocking Agents ("Muscle Relaxants")
Non-depolarising and Depolarising [1]
"This is one reason why we need muscle relaxants when administering general anaesthesia" [1] — the photograph shows an ETT passing between the vocal cords. NMBAs can improve intubating and surgical conditions, but they are not required for every GA or every airway device.
| Type | Subtype | Examples | Onset | Duration | Key Points |
|---|---|---|---|---|---|
| Non-depolarising | Short-acting | Mivacurium | Slower | ~15 min | Competitive antagonist at nicotinic AChR |
| Intermediate-acting | Atracurium, Cis-atracurium, Rocuronium, Vecuronium | 60–90s (Roc), 3 min (Atr) | 30–45 min | Rocuronium: most commonly used; Atracurium: Hofmann elimination (non-organ dependent — useful in liver/renal failure) | |
| Long-acting | Pancuronium | Slower | 60–90 min | Vagolytic → tachycardia | |
| Depolarising | — | Suxamethonium (succinylcholine / "scoline") | Rapid: 45 seconds | Ultra-short: 9–10 min | Initial fasciculations → depolarisation block. Side effects: hyperkalaemia, ↑ICP, ↑IOP, malignant hyperthermia, suxamethonium apnoea |
High Yield — Suxamethonium
Suxamethonium has a very rapid onset (about 45–60 seconds) and short duration. Suxamethonium or high-dose rocuronium are accepted fast-onset options for rapid-sequence induction when the airway must be secured promptly. [10] Important suxamethonium hazards include:
- Hyperkalaemia: Dangerous in burns (> 24h old), spinal cord injury, neuromuscular diseases, prolonged immobility — due to upregulation of extrajunctional nicotinic receptors → massive K⁺ efflux
- Malignant hyperthermia: Rare but fatal if untreated (treat with dantrolene)
- Suxamethonium apnoea: Patients with pseudocholinesterase deficiency cannot metabolize it → prolonged paralysis
- Fasciculations → muscle pain, ↑IOP, ↑ICP, ↑intragastric pressure
Rocuronium 0.9–1.2 mg/kg is a non-depolarising alternative for rapid-sequence induction. Availability of sugammadex is useful, but it does not replace a failed-airway plan. [10]
Nerve stimulator used to assess degree of neuromuscular blockade [1]
Train-of-Four (TOF): four stimuli at 0.5-second intervals, commonly delivered to the ulnar nerve with the response measured at adductor pollicis. A twitch count describes deeper block; once four responses return, a quantitative ratio detects residual fade that cannot be judged reliably by sight or touch. Confirm TOF ratio ≥0.9 before extubation. [10]
After induction and muscle relaxation:
Instrument airway → Endotracheal tube (ETT) secured with tape → connected to anaesthetic machine via the circuit → ventilator pumps gases into lungs [1]
- Bag-mask ventilation photographs: the mask is held with a seal while the breathing bag/circuit delivers oxygen and ventilation before the definitive airway is placed. A two-person technique can improve seal and jaw lift.
- Direct laryngoscopy photograph: the operator looks directly along the laryngoscope blade to expose the larynx.
- Video-laryngoscopy photograph: a camera near the blade tip displays the laryngeal view on a monitor; tube delivery still requires coordination and does not guarantee success.
- ETT photograph: the cuffed tube passes through the vocal cords into the trachea, is secured at the mouth and connects through the corrugated breathing circuit to the anaesthetic machine. A cuffed tracheal tube reduces—but does not abolish—aspiration risk.
- Ventilator-screen photograph: the displayed values include set and measured tidal volume, respiratory rate, airway pressures and the pressure waveform. These must be interpreted with the patient, capnogram and oxygenation rather than in isolation.
- Supraglottic airway (e.g. LMA): sits above the glottis. It is less invasive than tracheal intubation but does not provide the same aspiration protection.
Oxygenation during onset of paralysis: after induction and an NMBA, the patient may become apnoeic before intubation is complete. Bag-mask ventilation is commonly used to maintain oxygenation, while the exact approach (including rapid-sequence techniques) depends on aspiration risk and the airway plan.
7. Maintenance of Anaesthesia
Continuous administration of a maintenance anaesthetic agent, usually in combination with an analgesic agent. Inhalational or intravenous route. [1]
Isoflurane, Sevoflurane, Desflurane, +/- Nitrous Oxide [1]
| Agent | Key Feature | MAC (% atm) | Blood:Gas Partition Coefficient | Notes |
|---|---|---|---|---|
| Sevoflurane | Non-irritant, pleasant smell | ~2.0 | 0.65 (low → fast onset/offset) | Good for induction AND maintenance |
| Desflurane | Very low blood solubility | ~6.0 | 0.42 (very low → fastest onset/offset) | Pungent — NOT for inhalational induction; excellent for rapid emergence; requires heated pressurized vaporizer |
| Isoflurane | Cost-effective | ~1.15 | 1.46 | Pungent; coronary steal controversy |
| Nitrous oxide | Weak agent; used as adjunct | ~105 (> 100 → cannot produce anaesthesia alone) | 0.47 | Second gas effect; diffusion hypoxia; avoid in closed gas spaces (bowel obstruction, pneumothorax) |
Concept: MAC (Minimum Alveolar Concentration) — The concentration of inhaled anaesthetic at 1 atm that prevents movement in response to a surgical stimulus in 50% of patients. Think of it as the ED50 for volatile agents. Lower MAC = more potent agent. MAC is additive — combining agents reduces the concentration of each needed.
Reading the machine photographs: the agent-specific vaporiser converts liquid volatile anaesthetic into a calibrated vapour and its dial sets the delivered concentration. The monitor displays inspired concentration (entering the patient) and end-tidal concentration (leaving the alveoli). End-tidal concentration approaches alveolar—and, after equilibration, brain—partial pressure. The slide’s desflurane vaporiser is heated and pressurised because desflurane is unusually volatile. [1]
Propofol [1]
- Propofol infusion for both induction and maintenance, often combined with remifentanil infusion
- Target-Controlled Infusion (TCI): Computerized pump calculates dose based on patient weight and age to maintain a target plasma or effect-site concentration [3]
- Advantages: No atmospheric pollution, reduced PONV, smooth emergence
- Unlike a volatile technique, there is no end-tidal propofol concentration to confirm delivery. Current monitoring guidance recommends processed EEG when TIVA is combined with neuromuscular blockade, alongside close inspection of the IV cannula, tubing and pump. [9]
8. Analgesic Agents Used Perioperatively
"Just because the patient is not aware of the trauma, does your body still 'feel' the pain?" [1] — YES, the surgical stress response occurs regardless of consciousness.
Simple: Paracetamol (PO, IV, PR), NSAIDs & COX-2 inhibitors (IV, suppositories) [1] Opioids: Fentanyl (IV, SC), Morphine (IV, PO), Oxycodone (IV, PO), Pethidine (IV) [1] Others: Tramadol, Gabapentinoids, Ketamine, Regional Techniques [1]
| Drug | Route | Key Points |
|---|---|---|
| Paracetamol | PO, IV, PR | Mechanism is incompletely defined; opioid-sparing, with hepatotoxicity in overdose or excessive cumulative dosing |
| NSAIDs (e.g., diclofenac, ketorolac) | PO, IV, PR | COX-1/2 inhibition → ↓prostaglandin synthesis; risks: GI bleeding, renal impairment, platelet dysfunction |
| COX-2 inhibitors (e.g., celecoxib, parecoxib IV) | PO, IV | Less GI/platelet side effects; CV risk with prolonged use |
| Fentanyl | IV, SC | Potent synthetic opioid; 100× more potent than morphine; rapid onset, short duration; used at induction to blunt intubation response |
| Morphine | IV, PO | Gold standard opioid; longer duration; histamine release → hypotension; active metabolite M6G accumulates in renal failure |
| Oxycodone | IV, PO | Semi-synthetic; less histamine release than morphine |
| Pethidine | IV | Synthetic opioid; less biliary spasm; risk of serotonin syndrome with MAOIs; norpethidine metabolite → seizures |
| Remifentanil | IV infusion | Ultra-short acting (nonspecific ester hydrolysis; context-sensitive half-time roughly 3–5 min); negligible residual analgesia after stopping, so a postoperative plan is required |
| Tramadol | PO, IV | Weak µ-agonist + noradrenaline/serotonin reuptake inhibition; can still cause respiratory depression; risks include seizures and serotonin toxicity |
| Gabapentinoids (gabapentin, pregabalin) | PO | α2δ calcium-channel ligands; selected neuropathic-pain indications, but routine perioperative use is limited by dizziness, sedation and respiratory-risk concerns |
| Ketamine (sub-anaesthetic dose) | IV | NMDA antagonist; anti-hyperalgesic; opioid-sparing; useful in chronic pain patients |
Exam Trap — Remifentanil
Remifentanil is metabolised rapidly by nonspecific esterases and has a context-sensitive half-time of only a few minutes. It therefore provides little residual analgesia after the infusion stops and must be transitioned to a longer-acting postoperative regimen. The linked 2025 MCQ contrasts this with morphine, pethidine and tramadol. [2]
Naloxone — a short-acting opioid antagonist titrated to restore adequate ventilation while avoiding abrupt loss of analgesia and acute withdrawal. Because it may wear off before the opioid, continued observation and repeated doses or an infusion may be required. Follow the local emergency protocol rather than a single memorised dose.
To reverse neuromuscular blockade, NOT hypnosis [1]
| Agent | Mechanism | Reverses | Key Points |
|---|---|---|---|
| Neostigmine + antimuscarinic | Anticholinesterase → ↑ACh at NMJ to compete with non-depolarising NMB | Best used once spontaneous recovery has reached a minimal block | Co-administer atropine or glycopyrrolate to limit bradycardia, secretions and bronchoconstriction; it has a ceiling effect and is unreliable for deep block |
| Sugammadex | Modified γ-cyclodextrin that encapsulates aminosteroid NMBs | Rocuronium and vecuronium | Dose depends on measured block depth; works for deep, moderate or shallow block, but not atracurium/cisatracurium, mivacurium or suxamethonium |
| Flumazenil | Competitive antagonist at benzodiazepine receptor | Benzodiazepine sedation | 0.2 mg IV q1min (max 1 mg); risk of resedation and seizures [4] |
| Naloxone | µ-opioid receptor antagonist | Opioid effects | See above |
High Yield — Neostigmine + Atropine, Why Together?
Neostigmine is a cholinesterase inhibitor → increases ACh at ALL cholinergic synapses (nicotinic AND muscarinic). At the NMJ (nicotinic), this reverses the paralysis. But at muscarinic receptors (heart, gut, secretory glands), excess ACh causes dangerous bradycardia, excessive secretions, and bronchoconstriction. Therefore, an anticholinergic (atropine or glycopyrrolate) is ALWAYS co-administered to block these muscarinic effects while allowing the nicotinic reversal to occur.
Reversal is guided by measurement
The nerve-stimulator slide is not merely showing whether four twitches are present. Current guidance favours quantitative monitoring at adductor pollicis, drug choice and dose based on block depth, and documented recovery to TOF ratio ≥0.9 before extubation. A patient already recovered quantitatively to ≥0.9 does not need pharmacological antagonism. [10]
Emergence: process of return to baseline physiologic function of all organ systems after the cessation of administration of general anaesthetic agent(s) [1]
Steps:
- Turn off volatile agent / stop propofol infusion
- Increase fresh gas flow to "wash out" volatile agent
- Reverse NMB (if residual) — assess with nerve stimulator
- Suction oropharynx
- Patient regains consciousness, spontaneous breathing, protective reflexes
- Extubate when airway, ventilation, consciousness and other clinical criteria are met and, after a non-depolarising NMBA, quantitative TOF ratio ≥0.9 is confirmed
Risks during emergence: Laryngospasm, bronchospasm, aspiration (hence fasting!), awareness, agitation/delirium, PONV, shivering.
11. Postoperative Management
Oral analgesia, Parenteral analgesia, Infusion, Patient Controlled Analgesia (PCA), Continuation of Regional Block (Epidural, Catheters along major plexus & nerves) [1]
Multimodal analgesia is the standard approach: combining paracetamol + NSAID + opioid ± regional technique to target different pain pathways, reduce opioid consumption, and minimize side effects (the WHO analgesic ladder adapted for acute pain).
PCA (Patient Controlled Analgesia): the patient activates a programmed opioid bolus with dose and lockout limits. These safeguards reduce risk but do not make PCA overdose-proof; monitoring, avoidance of proxy activation and adjustment for comorbidity remain essential.
Home, Ward, High Dependency Unit (HDU), Intensive Care Unit (ICU). If you are not sure, ask the anaesthesiologist. [1]
Factors determining disposition: premorbid status, nature/length of operation, intraoperative events, anticipated postoperative complications, level of monitoring/support needed. [5]
12. Regional Anaesthesia (RA) — Detailed
Established by the deposition of local anaesthetic in close proximity to a nerve or a group of nerve fibres. The local anaesthetic blocks transmission of signals → reduced sensation from the anatomical area supplied by the blocked nerves. [1]
RA may be used alone or in combination with sedation or general anaesthesia. Pain relief is provided by nerve blockade; hypnosis is provided by the sedative agent. Sometimes the regional anaesthesia technique does not cover the entire surgical field → combination with GA is required. [1]
How LAs work: LAs bind voltage-gated Na⁺ channels from the intracellular side and prevent action-potential propagation. Fibre diameter, myelination, firing frequency, drug concentration and geometry all influence susceptibility; in practice, autonomic and sensory function often disappear before dense motor function, producing differential block.
Neuraxial blocks (spinal, epidural), plexus blocks, nerve blocks, local infiltration, topical anaesthesia, intravenous regional technique [1]
| Type | Site of LA Deposition | Key Features |
|---|---|---|
| Spinal (subarachnoid / intrathecal) | Into CSF | Dense block ("temporary paraplegia"); motor + sensory; single injection; rapid onset; blocks sensation below a certain level depending on the type and dose of LA used [1]; used for lower abdominal/pelvic/lower limb surgery; e.g., C-section |
| Epidural | Epidural space (outside dura) | Variable motor/sensory block; can place catheter for continuous infusion; used for labour analgesia, thoracic/abdominal surgery |
| Plexus block | Near nerve plexus (e.g., brachial plexus) | Arm surgery |
| Nerve block | Near individual nerve (e.g., femoral nerve) | Specific dermatome/myotome |
| Local infiltration | Directly into tissues | Minor procedures (wound suturing, excisions) |
| Topical | Skin/mucosal surface | EMLA cream (lignocaine + prilocaine), lignocaine spray for laryngoscopy |
| IV regional (Bier's block) | IV injection into exsanguinated limb with tourniquet | Short procedures on forearm/hand |
How to read the neuraxial diagram: from posterior to anterior, the needle traverses skin/ligaments to reach the epidural space outside the dura; a spinal needle continues through dura into the CSF-containing subarachnoid (intrathecal) space. This anatomical difference explains why spinal anaesthesia uses a small intrathecal dose with rapid dense block, whereas an epidural can be titrated through a catheter using larger volumes.
| LA | Class | Relative profile | Key Points |
|---|---|---|---|
| Lignocaine (lidocaine) | Amide | Fast onset, intermediate duration | Widely used; also a class Ib anti-arrhythmic |
| Bupivacaine | Amide | Slower onset, long duration | Greater cardiotoxic potential; common in spinal/epidural anaesthesia |
| Ropivacaine | Amide | Intermediate onset, long duration | Less cardiotoxic and often less motor block than racemic bupivacaine |
| Levobupivacaine | Amide | Intermediate onset, long duration | S-enantiomer of bupivacaine |
| Prilocaine | Amide | Intermediate profile | Can cause methaemoglobinaemia; used in selected IV regional techniques |
Local-anaesthetic doses are not one universal number
Maximum dose varies with agent, concentration, route/site, use of a vasoconstrictor, patient size, age, pregnancy, organ function and whether other local anaesthetics have already been given. Calculate the total cumulative dose from every operator and use the current institutional/product limit.
Role of adrenaline with LA: [6]
- Local vasoconstriction can slow systemic absorption, prolong block and help reveal accidental intravascular injection through a haemodynamic response.
- The traditional blanket rule “never use adrenaline in fingers, toes, nose, pinna or penis” is too absolute. Dilute preparations are used safely in selected sites, but avoid them when perfusion is compromised and follow the procedure-specific/local protocol.
- 1% solution = 10 mg/mL and 0.5% = 5 mg/mL.
- If the chosen protocol sets a patient-specific maximum of 210 mg, the corresponding volume of 0.5% solution is 210 ÷ 5 = 42 mL. The arithmetic does not establish that 210 mg is safe for every patient or technique.
13. Complications of Regional Anaesthesia
Inadvertent intravascular injection, Overdose, Adverse reaction to adjuvant (e.g., epinephrine, preservatives) [1]
Spectrum of systemic manifestations: Neurological symptoms → Convulsions → Cardiovascular collapse [1]
The slide presents a useful CNS → seizure → cardiovascular collapse teaching sequence, but real LAST can be atypical: cardiovascular toxicity may occur without warning CNS excitation, and onset may be delayed after infiltration or an infusion. [11]
| Stage | Manifestations |
|---|---|
| Early CNS | Perioral numbness, metallic taste, tinnitus, dizziness, visual disturbance |
| CNS excitation | Tremors, convulsions |
| CNS depression | Loss of consciousness, respiratory depression |
| CVS toxicity | Hypotension, bradycardia, arrhythmias (VF), cardiac arrest |
Classic mechanism: lower toxic concentrations preferentially suppress inhibitory cortical pathways, producing excitation/seizures; higher concentrations cause global CNS depression and direct cardiac conduction/contractility toxicity. Do not wait for every classic prodrome before acting.
Management of potentially serious LAST: [11]
- Stop injecting LA
- Call for help, bring the LAST rescue kit/checklist and prioritise oxygenation/ventilation; hypoxia, hypercapnia and acidosis worsen toxicity
- Treat seizures promptly, preferably with a benzodiazepine; avoid large propofol doses in cardiovascular instability
- Give 20% lipid emulsion early for a serious event according to the weight-based checklist; propofol is not a substitute
- If arrest occurs, use modified LAST resuscitation: smaller-than-usual adrenaline doses are preferred, avoid vasopressin, calcium-channel blockers and beta-blockers, and prefer amiodarone for ventricular arrhythmia
- Continue monitored care after apparent recovery because recurrence/delayed toxicity can occur
Risk reduction for LAST: [6,11]
- Calculate the patient-specific cumulative dose and label/communicate every local-anaesthetic contribution
- Aspirate and inject incrementally while maintaining verbal contact and monitoring; a negative aspiration does not exclude intravascular placement
- Use ultrasound appropriately for peripheral blocks, while recognising that visualisation does not eliminate risk
- Consider an adrenaline-containing test marker when appropriate; absence of a haemodynamic response is not proof of extravascular injection
- Keep the LAST checklist and 20% lipid emulsion immediately available wherever potentially toxic doses are used
Hypotension: Sympathectomy, inadequate intravascular volume, inappropriate patient choice (cardiac/valvular disease) [1] Bradycardia: Blockade of cardiac sympathetic fibres [1]
Why? Spinal/epidural anaesthesia blocks sympathetic fibres → arteriolar vasodilation (↓SVR) and venodilation (↓venous return) → hypotension. A high block may impair T1–T4 cardiac accelerator fibres; reduced venous return also promotes vagal bradycardia. Treat promptly with positioning, appropriately selected IV fluid and vasopressor, and atropine when indicated; the exact strategy varies by setting (especially obstetrics and fixed-output lesions).
Excessive rostral spread of LA — dose too much, position head down, subdural injection [1] Respiratory distress: motor blockade of intercostal muscles → may require ventilatory support [1] The slide labels the extreme endpoint “total spinal” and attributes it to supraspinal blockade. [1]
Current physiological interpretation: a high/total neuraxial block is excessive cephalad spread causing profound sympathectomy and high motor block. Respiratory failure can follow intercostal and then diaphragmatic impairment; severe hypotension/bradycardia may reduce cerebral perfusion and cause loss of consciousness. It is not best understood as local anaesthetic routinely bathing and anaesthetising the brainstem. This is an emergency: call for help, give oxygen, secure/ventilate the airway as required and provide aggressive cardiovascular support.
Conversion from RA to GA may be required immediately for several reasons: [1]
- Total or partial failure of block (see below)
- Complications from the regional technique — LA toxicity, severe haemodynamic disturbances, excessive block
- Prolonged surgery — duration of surgery exceeds duration of block → return of sensation during surgery
- Patient factors during surgery — restlessness or becoming uncooperative
Reasons for total or partial block failure: [1]
Operator factors: Misplaced needle, Incorrect dosage, Drug error (including expired drugs) Patient factors: Anatomical variants
| System | Effects | Mechanism |
|---|---|---|
| Respiratory | Respiratory depression, ↓cough reflex, ↓lung volumes, ↑V/Q mismatch, bronchospasm, retained secretions → post-op pneumonia | Central respiratory centre depression; loss of airway reflexes; diaphragm displacement; atelectasis [3] |
| Cardiovascular | ↓CO, vasodilation, hypotension, arrhythmias, myocardial depression | Direct drug effects (propofol, volatile agents); loss of sympathetic tone |
| Hepatic | ↓Drug metabolism, ↓albumin production, impaired clotting | Reduced hepatic blood flow; direct drug effects |
| Renal | ↓GFR, ↓urine output, electrolyte disturbance | ↓Renal blood flow from ↓CO and ↓MAP |
| Endocrine | Stress response (↑cortisol, catecholamines, glucose), worsened diabetic control | Surgical stress + anaesthetic effects |
Surgery plus general anaesthesia equals gross disturbances in physiological homeostasis. Effects extend well into the post-operative period. Patient assessment and optimization. Notify your anaesthetic colleagues early. [1]
High Yield Summary
- GA goals: hypnosis, amnesia, analgesia, areflexia and, when required, muscle relaxation.
- Paralysis is not anaesthesia: NMBAs provide no hypnosis, amnesia or analgesia.
- Elective fasting framework: 2 h clear fluid, 4 h breast milk, 6 h formula/light meal; heavy/fatty meals commonly need ≥8 h, with individualisation for aspiration risk and local policy.
- Induction: propofol is common; etomidate and ketamine may better preserve haemodynamics in selected patients; sevoflurane enables inhalational induction.
- Maintenance: sevoflurane/desflurane/isoflurane ± N₂O or propofol TIVA; read inspired and end-tidal agent concentrations on the monitor.
- NMB management: suxamethonium or high-dose rocuronium can provide rapid onset; use quantitative TOF and confirm ≥0.9 before extubation.
- Reversal: neostigmine plus an antimuscarinic for minimal recoverable block; sugammadex for rocuronium/vecuronium according to measured depth.
- Multimodal analgesia: combine compatible non-opioid, opioid and regional options; remifentanil has negligible residual postoperative effect after stopping.
- Regional anatomy: spinal drug enters CSF; epidural drug/catheter remains outside dura; peripheral blocks target plexus or individual nerves.
- Regional emergencies: recognise atypical LAST early and use the 20% lipid-emulsion checklist; high/total neuraxial block requires immediate respiratory and cardiovascular support.
- Plan for failure/conversion: assess, monitor and prepare equipment/drugs even when regional anaesthesia is intended.
Active Recall - Lecture Notes
[1] Lecture slides: GC 001 - How would you anaesthetise me - Pharmacology of anaesthetic drugs.pdf (all pages) [2] Past papers: 2025 Fourth Summative MCQ.pdf (Question 59) [3] Senior notes: Gen Clerk Anaes + Microbiology Summary.pdf (p1, p5) [4] Senior notes: Maksim Surgery Notes.pdf (p291, p305) [5] Lecture slides: Preoperative Assessment.pdf (p19) [6] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (p109); Maksim Surgery Notes.pdf (p295); Crisis Management.pdf (p9) [7] American Society of Anesthesiologists. Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia (2019); Practice Guidelines for Sedation and Analgesia by Non-Anesthesiologists. [8] American Society of Anesthesiologists Task Force on Preoperative Fasting. Practice Guidelines for Preoperative Fasting (2017), with the 2023 modular update for carbohydrate-containing clear liquids, chewing gum and paediatric fasting. Anesthesiology. 2017;126:376–393; 2023;138:132–151. [9] Klein AA, Meek T, Allcock E, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2021. Anaesthesia. 2021;76:1212–1223. doi:10.1111/anae.15501. [10] Thilen SR, Weigel WA, Todd MM, et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade. Anesthesiology. 2023;138:13–41; Fuchs-Buder T, Romero CS, Lewald H, et al. Peri-operative management of neuromuscular blockade: ESAIC guideline. Eur J Anaesthesiol. 2023;40:82–94. [11] American Society of Regional Anesthesia and Pain Medicine. Local Anesthetic Systemic Toxicity Checklist (2020, v1.1); Neal JM, Barrington MJ, Fettiplace MR, et al. Third ASRA Practice Advisory on Local Anesthetic Systemic Toxicity. Reg Anesth Pain Med. 2018;43:113–123.
Molecular Pathology Seminar 8: Molecular Genetic Testing In Breast Cancer With Case Study
Molecular genetic testing in breast cancer involves analyzing tumor biomarkers such as HER2 amplification, estrogen/progesterone receptor status, and gene expression profiles (e.g., Oncotype DX, MammaPrint) to guide prognosis, predict therapeutic response, and personalize treatment decisions.
GC002 Is He Fit For Surgery - Pre-operative Assessment
Pre-operative assessment is a systematic evaluation of a patient's medical history, physical status, and risk factors to determine their fitness for surgery and optimize outcomes.